MARKET

ARCT

ARCT

Arcturus Therape
NASDAQ
6.25
+0.12
+1.96%
After Hours: 6.24 -0.01 -0.16% 18:39 01/02 EST
OPEN
6.19
PREV CLOSE
6.13
HIGH
6.33
LOW
6.11
VOLUME
424.39K
TURNOVER
--
52 WEEK HIGH
24.17
52 WEEK LOW
5.85
MARKET CAP
177.59M
P/E (TTM)
-2.5408
1D
5D
1M
3M
1Y
5Y
1D
UK'S MHRA: APPROVED ZAPOMERAN (KOSTAIVE) MRNA COVID-19 VACCINE, FOR IMMUNISATION OF INDIVIDUALS AGED 18 YEARS AND OLDER
Reuters · 1d ago
Arcturus Therapeutics files $500M mixed securities shelf
TipRanks · 12/30/2025 21:05
Arcturus Therapeutics Holdings Files For Mixed Shelf Of Up To $500M
Benzinga · 12/30/2025 21:04
ARCTURUS THERAPEUTICS HOLDINGS INC FILES FOR MIXED SHELF OF UP TO $500 MLN - SEC FILING
Reuters · 12/30/2025 21:01
Weekly Report: what happened at ARCT last week (1222-1226)?
Weekly Report · 12/29/2025 10:22
Weekly Report: what happened at ARCT last week (1215-1219)?
Weekly Report · 12/22/2025 10:22
Arcturus Therapeutics Files Initial Beneficial Ownership Statement for Controller Joseph Roberts
Reuters · 12/19/2025 22:20
Arcturus Therapeutics Announces CFO Departure and Replacement
TipRanks · 12/15/2025 14:00
More
About ARCT
Arcturus Therapeutics Holdings Inc. is a commercial mRNA medicines and vaccines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. The Company with enabling technologies, including LUNAR lipid-mediated delivery, STARR mRNA technology (sa-mRNA) and mRNA drug substances along with drug product manufacturing. It has developed KOSTAIVE, a self-amplifying messenger RNA (sa-mRNA) COVID vaccine. The Company’s pipeline includes RNA therapeutic candidates to potentially treat ornithine transcarbamylase (OTC) deficiency and cystic fibrosis (CF), along with its partnered mRNA vaccine programs for SARS-CoV-2 (COVID-19) and influenza. The Company's versatile RNA therapeutics platforms can be applied to multiple types of nucleic acid medicines, including messenger RNA, small interfering RNA, circular RNA, antisense RNA, self-amplifying RNA, DNA, and gene editing therapeutics.

Webull offers Arcturus Therapeutics Holdings Inc stock information, including NASDAQ: ARCT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARCT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ARCT stock methods without spending real money on the virtual paper trading platform.